The prognostic significance of the Gleason grading system has been well established. However, individual Gleason patterns comprise heterogeneous morphologies which might add additional prognostic information. Recent evidence suggests that Gleason pattern 4 with cribriform growth pattern is associated with an adverse prognosis. To determine the association between cribriform pattern on biopsies and pathological findings on subsequent prostatectomies, we evaluated the presence of cribriform architecture in a prospective cohort of 367 men from 2014 to 2018 treated at a single institution. Cribriform architecture was present in 63.5% of all biopsies and was correlated with the overall extent of Gleason pattern 4. In addition, cribriform morphology on biopsy showed a statistically significant association with higher Gleason grade and increased pathological stage and nodal metastasis. In a subset analysis of cases with Grade Group 2 (Gleason score 3 + 4, n = 208), these associations did not reach statistical significance, but the presence of cribriform growth in this subgroup showed a trend toward increased upgrading to Grade Group 5 (Gleason score 9/10) (1 [0.5%] vs. 5 [2.4%], P = 0.06). This large prospective study comparing biopsy and prostatectomy finding of cribriform architecture demonstrates that cribriform pattern 4 is associated with adverse prognostic features and highlights the relevance for recognizing specific morphologies with distinct biological and clinical features.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2020.02.004DOI Listing

Publication Analysis

Top Keywords

gleason pattern
12
associated adverse
12
cribriform architecture
12
cribriform
9
gleason
8
pattern cribriform
8
cribriform morphology
8
morphology biopsy
8
cribriform growth
8
pattern associated
8

Similar Publications

Purpose: To investigate the utility of qualitative and semi-quantitative evaluation of DCE-MRI for detecting clinically significant prostate cancer (csPC).

Methods: This retrospective study analyzed 307 lesions in 231 patients who underwent 3.0T MRI.

View Article and Find Full Text PDF
Article Synopsis
  • Prostate cancer (PCa) is complex and often shows multiple tumor regions with different levels of severity, which this study investigated using advanced techniques like spatial transcriptomics to look at gene expression patterns in areas with different Gleason scores (GSs).
  • The analysis revealed clear relationships between gene expression and the histological characteristics of varying GSs, showcasing how tumor malignancy increases as the Gleason score rises.
  • A specific gene, RBM39, was notably linked to GS progression through gene comparison techniques, and this finding was validated with additional data from the Cancer Genome Atlas, as well as through laboratory experiments.
View Article and Find Full Text PDF

Prostatic adenocarcinomas with large cribriform glands/intraductal carcinoma (LC/IDC), or the recently proposed unfavorable histology, are associated with adverse outcomes after radical prostatectomy. However, Gleason pattern 4 carcinomas without LC/IDC (or unfavorable histology) have minimal risk for aggressive clinical behavior after prostatectomy. As proof-of-principle study, we collected a cohort of 485 radical prostatectomy specimens to assess correlations between different subtypes of Gleason pattern 4 disease and the presence of adjacent high-risk prostatic adenocarcinoma, defined as LC/IDC or unfavorable histology.

View Article and Find Full Text PDF

Advanced prostate cancer (aPCa) often results in bone metastases (BM). However, the mechanism underlying its progression and metastasis to bones remains unclear. Therefore, we examined whether exosomal miR-140-3p affects prostate cancer (PCa) progression.

View Article and Find Full Text PDF

Background And Objective: Focal therapy is increasingly being used as a treatment for localized prostate cancer (PC). Our aim was to evaluate oncological outcomes, recurrence patterns, and survival after high-intensity focused ultrasound (HIFU), to discuss the lessons learned from our experience, and to propose strategies to enhance patient selection for HIFU treatment.

Methods: Between 2016 and 2023, 113 patients underwent focal HIFU treatment for PC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!